Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/17051
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRosenzweig, I-
dc.contributor.authorGlasser, M-
dc.contributor.authorCrum, WR-
dc.contributor.authorKempton, MJ-
dc.contributor.authorMilosevic, M-
dc.contributor.authorMcMillan, A-
dc.contributor.authorLeschziner, GD-
dc.contributor.authorKumari, V-
dc.contributor.authorGoadsby, P-
dc.contributor.authorSimonds, AK-
dc.contributor.authorWilliams, SCR-
dc.contributor.authorMorrell, MJ-
dc.date.accessioned2018-11-05T15:41:08Z-
dc.date.available2016-05-01-
dc.date.available2018-11-05T15:41:08Z-
dc.date.issued2016-
dc.identifier.citationEBioMedicine, 2016, 7 pp. 221 - 229en_US
dc.identifier.issnhttp://dx.doi.org/10.1016/j.ebiom.2016.03.020-
dc.identifier.issn2352-3964-
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/17051-
dc.description.abstractBackground: Obstructive sleep apnea (OSA) is a chronic, multisystem disorder that has a bidirectional relationship with several major neurological disorders, including Alzheimer's dementia. Treatment with Continuous Positive Airway Pressure (CPAP) offers some protection from the effects of OSA, although it is still unclear which populations should be targeted, for how long, and what the effects of treatment are on different organ systems. We investigated whether cognitive improvements can be achieved as early as one month into CPAP treatment in patients with OSA. Methods: 55 patients (mean (SD) age: 47.6 (11.1) years) with newly diagnosed moderate-severe OSA (Oxygen Desaturation Index: 36.6 (25.2) events/hour; Epworth sleepiness score (ESS): 12.8 (4.9)) and 35 matched healthy volunteers were studied. All participants underwent neurocognitive testing, neuroimaging and polysomnography. Patients were randomized into parallel groups: CPAP with best supportive care (BSC), or BSC alone for one month, after which they were re-tested. Findings: One month of CPAP with BSC resulted in a hypertrophic trend in the right thalamus [mean difference (%): 4.04, 95% CI: 1.47 to 6.61], which was absent in the BSC group [- 2.29, 95% CI: - 4.34 to - 0.24]. Significant improvement was also recorded in ESS, in the CPAP plus BSC group, following treatment [mean difference (%): - 27.97, 95% CI: - 36.75 to - 19.19 vs 2.46, 95% CI: - 5.23 to 10.15; P = 0.012], correlated to neuroplastic changes in brainstem (r = - 0.37; P = 0.05), and improvements in delayed logical memory scores [57.20, 95% CI: 42.94 to 71.46 vs 23.41, 95% CI: 17.17 to 29.65; P = 0.037]. Interpretation: One month of CPAP treatment can lead to adaptive alterations in the neurocognitive architecture that underlies the reduced sleepiness, and improved verbal episodic memory in patients with OSA. We propose that partial neural recovery occurs during short periods of treatment with CPAP.en_US
dc.format.extent221 - 229-
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.titleChanges in Neurocognitive Architecture in Patients with Obstructive Sleep Apnea Treated with Continuous Positive Airway Pressureen_US
dc.typeArticleen_US
dc.identifier.doihttp://dx.doi.org/10.1016/j.ebiom.2016.03.020-
dc.relation.isPartOfEBioMedicine-
pubs.publication-statusPublished-
pubs.volume7-
dc.identifier.eissn2352-3964-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
Fulltext.pdf976.23 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.